Beyond CA-125: How New Biomarkers Are Transforming Ovarian Cancer...

Ajouter une nouvelle offre d'emploi Health

2026-10-21 05:42:23 - Traduire -

Beyond CA-125: How New Biomarkers Are Transforming Ovarian Cancer Diagnostics

For years, CA-125 was the only blood biomarker routinely used in ovarian cancer diagnostics — and it was never good enough on its own. It can be elevated by endometriosis, pregnancy, or inflammation, and it fails to rise in a meaningful share of early-stage cancers. That limitation has driven a wave of research into new biomarkers and multi-marker panels, and the results are beginning to...

0 Commentaires 0 Parts 35 Vue 0 Aperçu